Regione Emilia-Romagna. Indicazioni pratiche per la sorveglianza e il controllo degli enterobatteri produttori di carbapenemasi in sanità pubblica e nel territorio: strutture socio-sanitarie, residenze private. 2011
Veneto. Protocollo operativo per la diagnosi, la sorveglianza e il controllo degli enterobatteri produttori di carbapenemasi nelle strutture sanitarie e socio-sanitarie. 2019
Updated guidelines on screening for carriage of resistant Enterobacteriaceae in Ireland. Dublin: Royal College of Physicians (RCPI). 2014
Circolare “Sorveglianza, e controllo delle infezioni da batteri produttori di carbapenemasi (CPE)”. Ministero della Salute, 2013
Systematic review of the effectiveness of infection control measures to prevent the transmission of carbapenemase-producing enterobacteriaceae through cross-border transfer of patients. ECDC Technical Report, 2014
Systematic review of the effectiveness of infection control measures to prevent the transmission of Extended-Spectrum Beta-Lactamase-producing Enterobacteriaceae through cross-border transfer of patients. ECDC, Technical report 2014
AHRQ. Carbapenem-Resistant Enterobacteriaceae (CRE) control and prevention toolkit. Agency for Healthcare Research and Quality U.S. Department of Health and Human Services, 2014
Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE) . CDC, November 2015 Update – CRE Toolkit
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Cl Microb Infect, 2014
Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party. Journal of Hospital Infection, 2016
